# FDA Inspection 1064584 - Sumitomo Dainippon Pharma Co., Ltd. - July 27, 2018

Source: https://www.globalkeysolutions.net/records/fda_inspections/sumitomo-dainippon-pharma-co-ltd/b88eaa22-935f-43cb-9ecc-eb8210e40ed4
Source feed: FDA_Inspections

> FDA Inspection 1064584 for Sumitomo Dainippon Pharma Co., Ltd. on July 27, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1064584
- Company Name: Sumitomo Dainippon Pharma Co., Ltd.
- Inspection Date: 2018-07-27
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1277764 - 2025-08-07](https://www.globalkeysolutions.net/records/fda_inspections/sumitomo-dainippon-pharma-co-ltd/43625239-cfee-4173-8772-0af3efdf143c)
- [FDA Inspection 1113228 - 2019-11-22](https://www.globalkeysolutions.net/records/fda_inspections/sumitomo-dainippon-pharma-co-ltd/1c86b0d4-989e-4cae-ad7f-4339b52c4cd9)
- [FDA Inspection 990466 - 2016-09-09](https://www.globalkeysolutions.net/records/fda_inspections/sumitomo-dainippon-pharma-co-ltd/151acf38-3655-484e-940e-d2c279207079)
- [FDA Inspection 853865 - 2013-11-01](https://www.globalkeysolutions.net/records/fda_inspections/sumitomo-dainippon-pharma-co-ltd/08db7714-ba67-434c-a54b-e91f0f392dfd)
- [FDA Inspection 770009 - 2012-02-23](https://www.globalkeysolutions.net/records/fda_inspections/sumitomo-dainippon-pharma-co-ltd/262a3d80-b465-4788-b2e0-b54347eb7b48)

Company: https://www.globalkeysolutions.net/companies/sumitomo-dainippon-pharma-co-ltd/40ead027-5fd5-4deb-a37b-40301cffd612

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c